Dietmar Berger
Chief Tech/Sci/R&D Officer presso SANOFI
Profilo
Dietmar P. Berger occupa la posizione di Chief Medical Officer & Global Head-Development presso Sanofi. Nella sua carriera passata ha ricoperto la posizione di Global Head-Research & Development presso Atara Biotherapeutics, Inc., Head-Clinical Research Centre presso Universittsklinikum Freiburg, Vice President-Clinical Hematology & Oncology presso Genentech, Inc. e Head-Clinical Research Centre presso The Scripps Research Institute. Il Dr. Berger ha conseguito una laurea e un dottorato presso l'Università di Friburgo.
Posizioni attive di Dietmar Berger
| Società | Posizione | Inizio |
|---|---|---|
| SANOFI | Chief Tech/Sci/R&D Officer | 01/01/2019 |
Precedenti posizioni note di Dietmar Berger
| Società | Posizione | Fine |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/05/2019 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/05/2018 |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | - |
Universitätsklinikum Freiburg
 Universitätsklinikum Freiburg Hospital/Nursing ManagementHealth Services Universitätsklinikum Freiburg operates as a teaching hospital. The company was founded by Archduke Albrecht VI in 1457 and is headquartered in Freiburg, Germany. | Corporate Officer/Principal | - |
Formazione di Dietmar Berger
| University of Freiburg | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SANOFI | Health Technology |
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Universitätsklinikum Freiburg
Universitätsklinikum Freiburg Hospital/Nursing ManagementHealth Services Universitätsklinikum Freiburg operates as a teaching hospital. The company was founded by Archduke Albrecht VI in 1457 and is headquartered in Freiburg, Germany. | Health Services |
- Borsa valori
- Insiders
- Dietmar Berger
